[Prevention of urotoxic complications during therapy with cytostatics. The problem of the interaction between sodium-II-mercaptoethanesulfonate and cyclophosphamide].
D000818:Animals; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D003556:Cystitis / Q000139:chemically induced / Q000517:prevention & control; D004247:DNA / Q000096:biosynthesis; D008623:Mercaptoethanol / Q000031:analogs & derivatives*; D015080:Mesna / Q000627:therapeutic use*; D051381:Rats
D008623:Mercaptoethanol; D003520:Cyclophosphamide; D004247:DNA; D015080:Mesna
Zur Prophylaxe urotoxischer Komplikationen bei Zytostatika-Therapie. Untersuchungen zur Frage der Wechselwirkung zwischen Natrium-II-Mercaptoethansulfonat und Cyclophosphamid.